IRIS Accounts Production v25.1.0.734 03178821 Board of Directors 1.1.24 31.12.24 31.12.24 24.6.25 0 0 true false true false false true true true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh031788212023-12-31031788212024-12-31031788212024-01-012024-12-31031788212022-12-31031788212023-01-012023-12-31031788212023-12-3103178821ns15:EnglandWales2024-01-012024-12-3103178821ns14:PoundSterling2024-01-012024-12-3103178821ns10:Director12024-01-012024-12-3103178821ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3103178821ns10:SmallEntities2024-01-012024-12-3103178821ns10:Audited2024-01-012024-12-3103178821ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3103178821ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3103178821ns10:FullAccounts2024-01-012024-12-3103178821ns10:Director22024-01-012024-12-3103178821ns10:Director32024-01-012024-12-3103178821ns10:Director42024-01-012024-12-3103178821ns10:Director52024-01-012024-12-3103178821ns10:RegisteredOffice2024-01-012024-12-3103178821ns5:CurrentFinancialInstruments2024-12-3103178821ns5:CurrentFinancialInstruments2023-12-3103178821ns5:ShareCapital2024-12-3103178821ns5:ShareCapital2023-12-3103178821ns5:RetainedEarningsAccumulatedLosses2024-12-3103178821ns5:RetainedEarningsAccumulatedLosses2023-12-3103178821ns5:CostValuation2023-12-31
REGISTERED NUMBER: 03178821 (England and Wales)

































Financial Statements

For The Year Ended

31 December 2024

for

LAKELAND CHEMICALS LIMITED

LAKELAND CHEMICALS LIMITED (REGISTERED NUMBER: 03178821)






Contents of the Financial Statements
For The Year Ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


LAKELAND CHEMICALS LIMITED

Company Information
For The Year Ended 31 December 2024







DIRECTORS: Mr P McCormack
Mr J R Clark
Mr E Seddon
Mrs C Buckley
Mrs S Oliver





REGISTERED OFFICE: Peel Lane
Astley Green
Tyldesley
Manchester
Greater Manchester
M29 7FE





REGISTERED NUMBER: 03178821 (England and Wales)





AUDITORS: Leavitt Walmsley Associates Limited
Chartered Certified Accountants and
Statutory Auditors
8 Eastway
Sale
Cheshire
M33 4DX

LAKELAND CHEMICALS LIMITED (REGISTERED NUMBER: 03178821)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Investments 4 2,712,228 2,712,228

CURRENT ASSETS
Debtors 5 63,998 64,039

CREDITORS
Amounts falling due within one year 6 6 5
NET CURRENT ASSETS 63,992 64,034
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,776,220

2,776,262

CAPITAL AND RESERVES
Called up share capital 100,000 100,000
Retained earnings 2,676,220 2,676,262
SHAREHOLDERS' FUNDS 2,776,220 2,776,262

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 June 2025 and were signed on its behalf by:





Mr P McCormack - Director


LAKELAND CHEMICALS LIMITED (REGISTERED NUMBER: 03178821)

Notes to the Financial Statements
For The Year Ended 31 December 2024

1. STATUTORY INFORMATION

Lakeland Chemicals Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
At the time of approving these financial statements, the directors have a reasonable expectation that the company will have sufficient resources available to continue in existence for the foreseeable future. Hence, the directors continue to adopt the going concern basis of accounting in preparing these financial statements.

Preparation of consolidated financial statements
The financial statements contain information about Lakeland Chemicals Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 400 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as it and its subsidiary undertaking are included by full consolidation in the consolidated financial statements of its parent, Lakeland Laboratories Holdings Limited, Peel Lane, Astley Green, Tyldesley, Manchester, M29 7FE.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost and are tested annually for evidence of impairment. Where there are indicators that the subsidiary is impaired, it is written down to recoverable amount and the impairment loss is recognised in profit and loss.

Financial instruments
A financial asset or financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit or loss. All other investments are subsequently measured at cost less impairment.

Debtors and creditors which fall due within one year are recorded in the financial statements at transaction price and subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors). Debtors are reviewed for impairment at each reporting date and any impairments are recorded in profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt.

Debtors do not carry interest and are stated at their nominal value.

Trade creditors are not interest-bearing and are stated at their nominal value.

Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.

LAKELAND CHEMICALS LIMITED (REGISTERED NUMBER: 03178821)

Notes to the Financial Statements - continued
For The Year Ended 31 December 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 January 2024
and 31 December 2024 2,712,228
NET BOOK VALUE
At 31 December 2024 2,712,228
At 31 December 2023 2,712,228

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Amts owed by subsidiary 63,998 64,039

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Bank loans and overdrafts 6 5

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Steven John Collings FCCA (Senior Statutory Auditor)
for and on behalf of Leavitt Walmsley Associates Limited

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Lakeland Laboratories Holdings Ltd.